FY2026 December Period Q1 Financial Summary [Japanese GAAP] (Consolidated)

Performance Overview

For Q1 of FY2026 December period, consolidated operating revenue was JPY 16,234 million (up 25.1% YoY), operating income was JPY 6,462 million (up 53.1% YoY), and net income attributable to owners of the parent was JPY 4,205 million (up 67.9% YoY), achieving record quarterly performance. The Securities and FX business significantly increased revenue and profit due to higher CFD trading volume, while the cryptocurrency business saw a decline in both revenue and profit due to a sluggish market.

Financial Position and Dividend Policy

Total assets amounted to JPY 1,349,483 million (decreased by JPY 57,326 million from previous fiscal year-end), and net assets were JPY 56,128 million (increased by JPY 3,111 million from previous fiscal year-end). The decrease was mainly due to reduced client cryptocurrency assets. The dividend policy is to maintain stable payments. The annual dividend forecast for FY2026 December period is JPY 54.76 per share, with a dividend payout ratio benchmark of at least 65% and a DOE threshold of 10%.

Overview of Business Combination

On March 27, 2026, GMO Financial Holdings acquired all shares of LASHIC Small Amount and Short Term Insurance Co., Ltd., making it a consolidated subsidiary renamed GMO Small Amount and Short Term Insurance Co., Ltd. This new entry into the insurance business aims to diversify financial services and create synergies. The acquisition cost was JPY 85 million, with goodwill of JPY 83 million planned to be amortized evenly over 5 years.

Regarding Earnings Guidance

Since the Securities & FX and Cryptocurrency businesses are strongly affected by market conditions, consolidated earnings guidance is not disclosed. Instead, operational indicators such as FX trading volume and equity commission trading value are disclosed monthly.